Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mustafa Karaoğlan
Adjunctive Everolimus Therapy for Treatment-Resistant Focal-Onset Seizures Associated With Tuberous Sclerosis: A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study
Turk Noroloji Dergisi
Neurology
Related publications
Double-Blind, Placebo Controlled, Crossover Study of Lamotrigine in Treatment Resistant Partial Seizures.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Minocycline as Adjunctive Treatment for Treatment-Resistant Depression: Study Protocol for a Double Blind, Placebo-Controlled, Randomized Trial (MINDEP2)
BMC Psychiatry
Psychiatry
Mental Health
Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study
Journal of Affective Disorders
Psychiatry
Clinical Psychology
Mental Health
Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
The Lancet
Medicine
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports
Nephrology
Tocilizumab in Patients With Adult-Onset Still’s Disease Refractory to Glucocorticoid Treatment: A Randomised, Double-Blind, Placebo-Controlled Phase III Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
American Journal of Psychiatry
Psychiatry
Mental Health
Sarilumab for the Treatment of Ankylosing Spondylitis: Results of a Phase II, Randomised, Double-Blind, Placebo-Controlled Study (ALIGN)
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial
Gut
Gastroenterology
